Bessemer Group’s Cogent Biosciences COGT Stock Holding History

Bessemer Group’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	+17	New	+$595	﹤0.01%	2456
2025 Q4	–	Sell	-86	Closed	-$1K	–	2552
2025 Q3	$1K	Buy	86 +23	+37%	+$272	﹤0.01%	2392
2025 Q2	$0	Hold	63	–	–	﹤0.01%	2429
2025 Q1	$0	Sell	63 -117	-65%	-$917	﹤0.01%	2485
2024 Q4	$1K	Hold	180	–	–	﹤0.01%	2326
2024 Q3	$2K	Buy	+180	New	+$1.75K	﹤0.01%	2181
2022 Q2	–	Sell	-282	Closed	-$2K	–	1888
2022 Q1	$2K	Hold	282	–	–	﹤0.01%	1715
2021 Q4	$2K	Hold	282	–	–	﹤0.01%	1752
2021 Q3	$2K	Hold	282	–	–	﹤0.01%	1595
2021 Q2	$2K	Hold	282	–	–	﹤0.01%	1509
2021 Q1	$2K	Buy	+282	New	+$2.71K	﹤0.01%	1455

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bessemer Group's COGT Position: Q2 2026 in Review

Bessemer Group opened a new position in Cogent Biosciences (COGT) in Q2 2026: 17 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2456 among its holdings. This is a return to the name: Bessemer Group previously reported a position in COGT as recently as Q3 2025.

Bessemer Group first reported a position in COGT in Q1 2021 and has held it in 11 quarters since. The position peaked at $2K in Q3 2024. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Bessemer Group held 17 shares of Cogent Biosciences worth $1K as of Q2 2026.
Cogent Biosciences was a new Bessemer Group position in Q2 2026.
Cogent Biosciences made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2456 holding.
Bessemer Group first reported a position in Cogent Biosciences in Q1 2021 and has held it in 11 quarters since.
Bessemer Group's Cogent Biosciences position peaked at $2K in Q3 2024.
324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.